Subsidiary of Shandong Oriental Ocean Sci-tech(002086.SZ) obtained medical device registration certificates for two products.
Dongfang Ocean (002086.SZ) announced that its wholly-owned subsidiary, Aweico Biotechnology Co., Ltd., has independently developed and obtained the registration approval from the Shandong Provincial Drug Administration for the proprietary peptide (CPP) detection kit (magnetic micro-particle chemiluminescence method) and the Oxidized Low-Density Lipoprotein (Ox-LDL) detection kit (magnetic micro-particle chemiluminescence method), both of which have obtained a medical device registration certificate.
Shandong Oriental Ocean Sci-tech (002086.SZ) announced that its wholly-owned subsidiary, AVCO Biotech Co., Ltd., independently developed and peptide (CPP) detection kit (magnetic chemiluminescence method) and oxidized low density lipoprotein (Ox-LDL) detection kit (magnetic chemiluminescence method) recently obtained registration approval from the Shandong Province Food and Drug Administration, and obtained medical device registration certificates.
The above-mentioned products have been approved for the market, further enriching AVCO Biotech Co., Ltd.'s product line in the field of clinical testing.
Related Articles
COSCO Shipping Holdings (01919) spent approximately HK$36.4097 million to repurchase 2.49 million shares on May 19th.
.png)
GREENTOWN SER (02869) spent HK$985,400 to repurchase 212,000 shares on May 19th.
WEIGAO GROUP (01066) spent approximately HK$773,700 on May 19 to repurchase 225,200 shares.
COSCO Shipping Holdings (01919) spent approximately HK$36.4097 million to repurchase 2.49 million shares on May 19th.
GREENTOWN SER (02869) spent HK$985,400 to repurchase 212,000 shares on May 19th.
WEIGAO GROUP (01066) spent approximately HK$773,700 on May 19 to repurchase 225,200 shares.
